Development and Impact of Multivariate Model-based Strategy to Target High-risk Patients of Postoperative Complication
HiRisP3
Improving Medication Safety: Development and Impact of Multivariate Model-based Strategy to Target High-risk Patients of Postoperative Complication
1 other identifier
observational
500
1 country
1
Brief Summary
The objective is therefore to create a risk score for ADEs in an orthopedic and traumatological surgery department. The study is an prospective, observational, cohort trial. A first step will consist of: (i) a collection of PIs carried out in an orthopedic and traumatological surgery department for 1 month, (ii) a score of the clinical impact of Pharmacist Interventions using the Clinical, Econnomic and organisationnal scale by method of consensus and (iii) a statistical analysis. Statistical analysis consists of (i) logistic regression modeling, (ii) performance measurement by discrimination and calibration, and internal validation by resampling. In a second step, external validation using a new sample will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2018
CompletedFirst Submitted
Initial submission to the registry
March 22, 2018
CompletedFirst Posted
Study publicly available on registry
March 29, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2018
CompletedOctober 15, 2018
March 1, 2018
28 days
March 22, 2018
October 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Major clinical impact pharmaceutical intervention
Occurrence of a major clinical impact pharmaceutical intervention according to the CLEO scale
1 day
Secondary Outcomes (1)
pharmaceutical intervention
1 day
Study Arms (2)
Primary cohort
Primary cohort : Cohort of patient between January and February 2017
Secondary cohort
Secondary cohort : Cohort of patient between February and March 2018
Interventions
collection of pharmaceutical interventions carried out by the pharmaceutical team in the care uni in Primary and secondary cohort
Eligibility Criteria
Adult patient hospitalized in the department of orthopaedic surgery and traumatology on university hospital of Montpellier
You may qualify if:
- Subject aged over 18 years
- Subject hospitalized in the department of orthopaedic surgery and traumatology on university hospital of Montpellier.
You may not qualify if:
- Vulnerable persons according to French law (pregnant women, adults under guardianship, persons deprived of liberty)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uhmontpellier
Montpellier, 34295, France
Study Officials
- STUDY DIRECTOR
Pierre RENAUDIN, Pharm D
University Hospital, Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2018
First Posted
March 29, 2018
Study Start
February 13, 2018
Primary Completion
March 13, 2018
Study Completion
June 15, 2018
Last Updated
October 15, 2018
Record last verified: 2018-03